BriaCell Therapeutics's market cap is currently C$26.63M. The company's EPS TTM is C$-17.991; its P/E ratio is ―; BriaCell Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ -20.49K	C$ -19.39K	C$ -19.44K	C$ -18.74K	C$ -18.74K
Operating Income	C$ -23.27M	C$ -15.29M	C$ 3.69M	C$ 1.38M	C$ 946.42K
EBITDA	C$ -27.22M	C$ -34.05M	C$ -17.49M	C$ -4.89M	C$ -5.74M
Net Income	C$ -20.30M	C$ -11.58M	C$ -2.89M	C$ 1.38M	C$ 602.68K
Balance Sheet
Cash & Short-Term Investments	C$ 21.25M	C$ 41.04M	C$ 57.27M	C$ 19.46K	C$ 146.71K
Total Assets	C$ 27.16M	C$ 42.58M	C$ 58.04M	C$ 478.31K	C$ 415.43K
Total Debt	C$ 0.00	C$ 0.00	C$ 25.99K	C$ 228.75K	C$ 301.33K
Net Debt	C$ -21.25M	C$ -41.04M	C$ -57.24M	C$ 209.29K	C$ 154.62K
Total Liabilities	C$ 30.94M	C$ 32.25M	C$ 782.24K	C$ 3.77M	C$ 1.06M
Stockholders' Equity	C$ -3.78M	C$ 10.33M	C$ 57.26M	C$ 0.00	C$ 0.00
Cash Flow
Free Cash Flow	C$ -23.74M	C$ -12.48M	C$ -7.75M	-	-
Operating Cash Flow	C$ -23.74M	C$ -12.48M	C$ -7.75M	-	-
Investing Cash Flow	C$ 0.00	C$ 0.00	C$ 0.00	-	C$ 1.02M
Financing Cash Flow	C$ 3.95M	C$ -3.74M	C$ 65.00M	C$ 1.08M	C$ 2.28M

Currency in CAD

BriaCell Therapeutics Earnings and Revenue History

Income Statement >

BriaCell Therapeutics Debt to Assets

Balance Sheet >

BriaCell Therapeutics Cash Flow

Cash Flow >

BriaCell Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing